peer-reviewed publication
CareDx Stock Rises as Study Shows Cell-Free DNA's Utility for Kidney Allograft Rejection Detection
The Nature Medicine study illustrated the value of CareDx's AlloSure test for monitoring kidney transplant rejection beyond stand-of-care measures.
Written by early OGM adopters, the framework describes best practices for the technology's clinical implementation for hematological malignancies.
The company's data, presented at a recent meeting and simultaneously published, showed performance results analogous to currently marketed tests.
AMP, CAP Release Guidelines for Use of In Silico Approaches for Validating NGS Data Pipelines
Labs should not let in silico data supplant physical specimens in bioinformatic validation and should understand the limitations of such data.
Avida Biomed Developing Hybridization-Based Methylation Sequencing Panels for Cancer Dx
The firm touts a new hybridization probe design, which it says will enable small, focused panels that reduce sequencing costs and assay time.